US Stock MarketDetailed Quotes
CGON CG Oncology
- 28.500
- -1.520-5.06%
Close May 10 16:00 ET
- 28.960
- +0.460+1.61%
Post 18:22 ET
1.90BMarket Cap-26267P/E (TTM)
30.245High28.200Low762.41KVolume30.010Open30.020Pre Close21.97MTurnover3.32%Turnover RatioLossP/E (Static)66.64MShares50.23052wk High3.34P/B655.50MFloat Cap28.20052wk Low--Dividend TTM23.00MShs Float50.230Historical High--Div YieldTTM6.81%Amplitude28.200Historical Low28.813Avg Price1Lot Size
About CG Oncology Company
CG Oncology, Inc. is a clinical biopharmaceutical company, which engages in the development and commercialization of bladder-sparing therapeutic for patients afflicted with bladder cancer. It offers cretostimogene, a product initially in clinical development for the treatment of patients with Non-Muscle Invasive Bladder Cancer (NMIBC). The company was founded by Alex Yeung and Paul A. DeRidder on September 24, 2010 and is headquartered in Irvine, CA.
Company Profile
SymbolCGON
Company NameCG Oncology
Listing DateJan 25, 2024
Issue Price19.00
Founded2010
CEOMr. Arthur Kuan
MarketNASDAQ
Employees61
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address400 Spectrum Center Drive,Suite 2040
CityIrvine
ProvinceCalifornia
CountryUnited States of America
Zip Code92618
Phone1-949-409-3700
Websitehttp://www.cgoncology.com
Company Executives
- Name
- Position
- Salary
- Arthur Kuan
- Chairman of the Board and Chief Executive Officer
- 3.74M
- Corleen M. Roche
- Chief Financial Officer and Secretary
- --
- Ambaw Bellete
- President and Chief Operating Officer
- 2.85M
- Dr. Vijay Kasturi, M.D.
- Chief Medical Officer
- 2.36M
- Victor Tong, Jr
- Independent Director
- --
- Dr. Brian Liu, M.D.
- Independent Director
- --
- Dr. Leonard E. Post, PhD
- Lead Independent Director
- 77.54K
- Dr. James J. Mule
- Independent Director
- 198.00K
- Susan E. Graf
- Independent Director
- 599.04K
- Hong Fang Song
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
